Schizoaffective disorder is more likely to occur in women and symptoms begin manifesting at a young age. Therapy
Psychosocial treatments have been found to improve outcomes related to schizoaffective disorder. Supportive psychotherapy and cognitive behavioral therapy are both helpful. Intensive case management (ICM) has been shown to reduce hospitalizations, improve adherence to treatment, and improve social functioning. With ICM, clients are assigned a case manager responsible for coordination of care and assisting clients to access supports to address needs in multiple areas related to well-being, including housing. Psychiatric/psychosocial rehabilitation is often a component of schizoaffective disorder treatment. This rehabilitation method focuses on solving community integration problems such as obtaining and keeping housing and increasing involvement in positive social groups. It also focuses on improving and increasing activities of daily living; increasing daily healthy habits and decreasing unhealthy behaviors, thereby significantly improving quality of life. Psychiatric rehabilitation may also focus on vocational rehabilitation. Evidence suggests that cognition-based approaches may be able to improve work and social functioning.Psychiatric rehabilitation consists of eight main areas:

Psychiatric (symptom reduction and management)
Health and Medical (maintaining consistency of care)
Housing (safe environments)
Basic living skills (hygiene, meals [including increasing healthy food intake and reducing processed food intake], safety, planning and chores)
Social (relationships, family boundaries, communication and integration of client into the community)
Education and vocation (coping skills, motivation and suitable goals chosen by client)
Finance (personal budget)
Community and legal (resources)

Medication
Antipsychotic medication is usually required both for acute treatment and the prevention of relapse.
Familial dysalbuminemic hyperthyroxinemia is a type of hyperthyroxinemia associated with mutations in the human serum albumin gene. The term was introduced in 1982. References


== External links ==